Immediate Impact
59 standout
Citing Papers
Understanding the complexity of p53 in a new era of tumor suppression
2024 Standout
Cancer therapy with antibodies
2024 Standout
Works of David D. Biggs being referenced
SGNLVA-002: Single-arm, open label phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresectable locally advanced or metastatic triple-negative breast cancer.
2019
Immunoglobulin gene sequence analysis to further assess B-cell origin of multiple myeloma
1995
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| David D. Biggs | 70 | 227 | 32 | 226 | 131 | 20 | 547 | |
| Lieke H. J. Simkens | 133 | 373 | 13 | 184 | 111 | 22 | 644 | |
| Peter Reese | 103 | 171 | 13 | 77 | 64 | 21 | 470 | |
| Olivia Turri | 56 | 86 | 8 | 79 | 52 | 14 | 519 | |
| J.-F. Geay | 82 | 175 | 19 | 145 | 106 | 14 | 470 | |
| Leah L. Dietrich | 47 | 161 | 11 | 255 | 136 | 18 | 499 | |
| D. N. Rao | 88 | 174 | 9 | 103 | 40 | 18 | 472 | |
| Florence Mercier | 132 | 141 | 63 | 148 | 28 | 29 | 586 | |
| I. N. Olver | 107 | 240 | 5 | 169 | 68 | 17 | 498 | |
| Ruy Geraldo Bevilacqua | 215 | 215 | 9 | 230 | 113 | 28 | 613 | |
| C. Collis | 125 | 89 | 102 | 161 | 69 | 26 | 474 |
All Works
Loading papers...